Funding rounds, M&A, IPOs, and market analysis—where capital is flowing and why the tape moves.
Emerging evidence reveals a critical link between oral health and pregnancy outcomes, emphasizing the role of care providers, states, and insurance plans in prioritizing dental care.
Emerging evidence reveals a critical link between oral health and pregnancy outcomes, emphasizing the role of care providers, states, and insurance plans in prioritizing dental care.
READ MORE
Signos has secured $20 million in funding to broaden its glucose monitoring platform's use, aiming to leverage CGM technology beyond diabetes management into weight loss and lifestyle optimization.
May 2026 witnessed significant funding rounds in health technology, underscoring continued investor confidence and accelerating innovation in digital health solutions.
May 2026 witnessed significant shifts in healthcare leadership across major organizations, alongside notable layoffs, signaling changes in strategic direction and operational priorities within the sector.
Apogee Therapeutics has entered a significant royalty financing agreement with Blackstone Life Sciences to fund pivotal clinical trials of its lead drug candidate targeting atopic dermatitis and other inflammatory conditions.
Germany's emerging biotech sector shows strong scientific foundations and early-stage support, yet Europe needs deeper capital pools, cross-border investor collaboration, and lighter regulatory frameworks to sustain growth.
Despite widespread adoption of precision medicine programs across health systems, scaling these initiatives remains hindered by reimbursement complexities, data integration issues, and patient engagement barriers, as highlighted in a new UPMC report.
Modern health plans are leveraging intelligent engagement through unified infrastructures to achieve growth efficiently. This post explores how payers can successfully do more with less in a competitive healthcare market.
The perimenopause movement, while offering greater awareness, is also giving rise to misinformation largely driven by influencers and supplement industries, raising concerns among experts about its true impact on women.
Selective contracting, AI integration, networking volatility, and a growing focus on value-based care are reshaping the dental and vision benefits landscape.
Recordati, the Italian pharmaceutical company, has received a $12.4 billion offer to go private, providing it with potential strategic advantages and stable capital.
